Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bard secures Venetec

This article was originally published in The Gray Sheet

Executive Summary

CR Bard announces April 10 that it has completed its $166 mil. acquisition of StatLock securement technology manufacturer Venetec International. Bard has estimated that the move will result in an additional $18 mil. in 2006 revenue (1"The Gray Sheet" March 6, 2006, In Brief)...

You may also be interested in...



Bard buy

CR Bard signs $166 mil. agreement March 1 to acquire catheter securement technology firm Venetec International. Bard, with net sales of $1.77 bil. in 2005, estimates the deal will increase 2006 revenue growth by one percentage point over prior expectations, to 10%-11%, or by roughly $18 mil. The deal is expected to close in the second quarter. San Diego-based Venetec makes the StatLock line of molded gripping devices, which provide an alternative to tape or sutures for holding catheters in place. The items are used in catheter insertion kits and trays sold by Bard and other firms. Bard CEO Timothy Ring said the StatLock devices "fit very well strategically" with leading Bard products, including central venous and peripherally inserted central catheters and Foley and dialysis catheters...

Zur Rose Calls For Swiss Online Liberalization To Manage Coronavirus OTC Demand

Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.

UK IVDs Firms Working Flat Out On COVID-19 Tests, As Govt Promises Test Capacity Increase

Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.

UsernamePublicRestriction

Register

MT023432

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel